EUVIMEDEUVIMED entdecken
Leserbrief

Hughes-Stovin syndrome (HSS) preliminary diagnostic criteria: a paradigm shift in managing pulmonary vasculitis in HSS and Behçet’s disease (BD). On behalf of the HSS International Study Group (HSSISG)

Yasser Emad, Tamer Gheita, Yasser Ragab, Nevin Hammam, Michael Kindermann, Ossama Ibrahim, Marianna Fabi, Faten Frikha, Khalid Alhusseiny, Jasna Tekavec-Trkanjec, Melek Kechida, Harrison W Farber und 29 weitere

Clinical Rheumatology · 2026-07 · 45 (7) · 3899-3903

DOI: 10.1007/s10067-026-08222-8 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Clinical Rheumatology, online erschienen am 19.06.2026. Verfasst von Yasser Emad und 40 weiteren Autor:innen. Beteiligte Einrichtung: Rheumatology Department, Faculty of Medicine, Cairo University, Kasr Al-Ainy St, Cairo, 11562, Egypt. yasseremad68@gmail.com. Hauptthemen laut MEDLINE: Behcet Syndrome, Pulmonary Artery, Aneurysm, Vasculitis. Die Arbeit nennt 16 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hughes-Stovin syndrome (HSS) is a rare and aggressive type of systemic vasculitis which is characterized by peripheral venous thrombosis and pulmonary artery aneurysms (PAAs) at the onset of the disease, as well as the absence of recent or previous attacks of uveitis. The onset of HSS and its dominant clinical disease presentations differ in many aspects from those observed in Behçet’s disease (BD). The absence of uveitis is a mandatory exclusion criterion in the preliminary diagnostic criteria proposed by the HSS International Study Group (HSSISG), to avoid misclassification between HSS and BD. The presence of PAAs is an obligatory “entry criterion” for diagnosis, while vascular thrombotic events are a “major criterion” after excluding other causes of coagulopathy-induced thrombosis. The HSSISG regards HSS and BD as one disease, yet exhibiting distinct patterns of disease expression, particularly at disease onset. Differentiating HSS from BD is especially important for early diagnosis and optimal management. While the presence of HLA-B51 is the strongest genetic risk factor for BD, it is not used as a criterion to confirm a diagnosis because it lacks sufficient specificity. The prevalence of HLA-B51 in HSS is relatively low, suggesting that different genetic drivers might exist or that HSS is a unique entity with overlapping features with BD. In HSS, both HLA-B51 positive and negative cases have been described; thus, it cannot be a hallmark of the syndrome, and it does not play a role in the diagnostic criteria.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Behcet SyndromePulmonary ArteryAneurysmVasculitisVenous ThrombosisHumansDiagnosis, Differential

Stichwörter der Autor:innen

Behçet’s disease (BD)HSS preliminary diagnostic criteriaHughes-Stovin syndrome (HSS)Pulmonary artery aneurysmsVasculitis

Autor:innen und Institutionen

  • Rheumatology Department, Faculty of Medicine, Cairo University, Kasr Al-Ainy St, Cairo, 11562, Egypt. yasseremad68@gmail.com.
  • Rheumatology Department, Faculty of Medicine, Cairo University, Kasr Al-Ainy St, Cairo, 11562, Egypt.
  • Radiology Department, Faculty of Medicine, Cairo University, Kasr Al-Ainy St, Cairo, 11562, Egypt.
  • Rheumatology Departments, Faculty of Medicine, Assiut University, Assiut, Egypt.
  • Innere Medizin III (Kardiologie/Angiologie), Universitätskliniken Des Saarlandes, Kirrberger Straße, D 66421, Homburg/Saar, Germany.
  • Morecambe Bay University Hospitals Lancaster, Lancashire, Ashton Rd, Lancashire, LA1 4RP, UK.

Zitieren

APA

Emad, Y., Gheita, T., Ragab, Y., Hammam, N., Kindermann, M., Ibrahim, O., Fabi, M., Frikha, F., Alhusseiny, K., Tekavec-Trkanjec, J., Kechida, M., Farber, H. W., Young, P., Pankl, S., Robinson, C., Tharwat, S., Guffroy, A., Jaramillo, N., Ruffer, N., …, & Rasker, J. J. (2026). Hughes-Stovin syndrome (HSS) preliminary diagnostic criteria: a paradigm shift in managing pulmonary vasculitis in HSS and Behçet’s disease (BD). On behalf of the HSS International Study Group (HSSISG). Clinical Rheumatology, 45(7), 3899-3903. https://doi.org/10.1007/s10067-026-08222-8

Vancouver

Emad Y, Gheita T, Ragab Y, Hammam N, Kindermann M, Ibrahim O, et al. Hughes-Stovin syndrome (HSS) preliminary diagnostic criteria: a paradigm shift in managing pulmonary vasculitis in HSS and Behçet’s disease (BD). On behalf of the HSS International Study Group (HSSISG). Clinical Rheumatology. 2026;45(7):3899-3903. doi:10.1007/s10067-026-08222-8

BibTeX
@article{Emad2026,
  author = {Emad, Yasser and Gheita, Tamer and Ragab, Yasser and Hammam, Nevin and Kindermann, Michael and Ibrahim, Ossama and Fabi, Marianna and Frikha, Faten and Alhusseiny, Khalid and Tekavec-Trkanjec, Jasna and Kechida, Melek and Farber, Harrison W and Young, Pablo and Pankl, Sonia and Robinson, Cal and Tharwat, Samar and Guffroy, Aurelien and Jaramillo, Natalia and Ruffer, Nikolas and Bawaskar, Parag and Kably, Issam and Abou-Zeid, Alaa and Hassan, Maged and Ghirardo, Sergio and Barman, Bhupen and Bennji, Sami and Agarwala, Manoj Kumar and Tornes, Leticia and Margolesky, Jason and Silva, Rafael S and Cruz, Vitor and Abdelbary, Mohamed H and Kim, Jung Tae and Cozzi, Diletta and Abdelali, Mabrouk and Joy, Tubig C and Sherwina, Juljani and Kassem, Iman A and Yasser, Farida and Ten Klooster, Peter M and Rasker, Johannes J},
  title = {Hughes-Stovin syndrome (HSS) preliminary diagnostic criteria: a paradigm shift in managing pulmonary vasculitis in HSS and Behçet’s disease (BD). On behalf of the HSS International Study Group (HSSISG)},
  journal = {Clinical Rheumatology},
  year = {2026},
  volume = {45},
  number = {7},
  pages = {3899--3903},
  doi = {10.1007/s10067-026-08222-8}
}
Kostenlos starten →